Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
health
biotech
boston blog main
boston top stories
clinical trials
life sciences
medicine
national blog main
national top stories
startups
akcea therapeutics
allosteric
anylam pharmaceuticals
apps
archive
atlas venture
atopic dermatitis
autoimmune disorders
bio
boston
brace pharma
cancer
cardiomyopathy
china
cleva pharma
coronavirus
deals
disease
drug discovery
drugs
dupilumab
electronic medical records
fda
first round capital
flatiron health
funding
fundings & exits
glaxosmithkline
healthcare
hotspot therapeutics
What
ago
6
×
disease
6
×
years
cdc
medicines
new
rare
states
united
address
adds
advisory
aggressive
akcea
allosteric
alnylam
amyloidosis
announced
app
approved
arrived
attacks
attr
available
battle
bizarre
blame
called
cancer
caused
centers
chat
chemo
china
chinese
clinic
competitor
confirms
control
coronavirus
Language
unset
unknown
Current search:
ago
×
disease
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@bgr.com
4 years ago
CDC confirms Chinese coronavirus has arrived in the US
@bgr.com
4 years ago
Mom of two was misdiagnosed with cancer, endured chemo and surgery before the mistake was found
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@slashgear.com
4 years ago
Don’t blame the measles vaccine for global outbreaks
@techcrunch.com
5 years ago
RDMD attacks rare diseases with data mined from health records